Lonza Tampa LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 5709 JOHNS RD SUITE 1209, TAMPA, Florida (FL) 33634, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 3001549109 · DUNS 080939373
FDA inspection history
Outcomes of closed FDA inspections at this site, every FDA program area; the official-action banner above considers Drug Quality Assurance inspections only.
- VAIDrug Quality Assurance2025-08-22
- VAIDrug Quality Assurance2023-09-29
- VAIDrug Quality Assurance2021-10-01
- VAIDrug Quality Assurance2018-07-20
- VAIDrug Quality Assurance2017-07-14
- VAIDrug Quality Assurance2008-12-10
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site for a manufacturing step (any MANUFACTURE-type role, API included). Counts are per distinct generic name (case-insensitive).
- LevoketoconazoleXeris Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.